title: Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.
abstract: This study aimed to evaluate the effects of volume adapted re-planning for radiotherapy (RT) after gross total resection (GTR) for glioblastoma. Nineteen patients with glioblastoma who underwent GTR and postoperative RT were analyzed. The volumes of the surgical cavity on computed tomography (CT) obtained one day after GTR (CT0), the first RT simulation CT (sim-CT1), and the second simulation CT for the boost RT plan (sim-CT2) were compared. The boost RT plan was based on the surgical cavity observed on the sim-CT2 (boost RTP2) and was compared with that based on the surgical cavity observed on the sim-CT1 (boost RTP1). The volume reduction ratios were 14.4%-51.3% (median, 29.0%) between CT0 and sim-CT1 and -7.9%-71.9% (median, 34.9%) between sim-CT1 and sim-CT2 (P < 0.001). The normal brain volumes in boost RTP1 were significantly reduced in boost RTP2, especially at high dose levels. Target volume in sim-CT2 which was not covered with the boost RTP1, developed in five cases (26.3%). The surgical cavity volume was reduced following surgery in patients with glioblastoma who underwent GTR. The application of volume-adapted re-planning during RT could decrease the irradiated volume of normal brain and prevent a target miss for boost RT.
authors: Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
authors: Tae Gyu
authors: TG
authors: Kim
authors: Do Hoon
authors: DH
authors: Lim
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D005909:Glioblastoma / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D014057:Tomography, X-Ray Computed
keywords: Brain; Glioblastomas; Radiotherapy, Image-Guided; Surgery
references: Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):319-30
references: 2841263
references: Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):144-50
references: 17306935
references: Radiother Oncol. 2000 Aug;56(2):151-6
references: 10927133
references: J Neurosurg. 1989 Jul;71(1):1-9
references: 2661738
references: J Neurosurg. 1987 Jun;66(6):865-74
references: 3033172
references: Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1405-9
references: 2542195
references: Semin Radiat Oncol. 2005 Jul;15(3):146-56
references: 15983940
references: Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):243-52
references: 6260715
references: J Cancer Res Ther. 2008 Jan-Mar;4(1):9-13
references: 18417895
references: Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1347-50
references: 2557310
references: Neurology. 1980 Feb;30(2):172-7
references: 6243762
references: Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):193-207
references: 8380567
references: Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S20-7
references: 20171513
references: J Neurosurg. 1983 Feb;58(2):159-69
references: 6294260
references: Radiother Oncol. 1999 Oct;53(1):53-7
references: 10624854
references: Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):210-21
references: 16472938
references: Am J Clin Oncol. 1995 Aug;18(4):297-9
references: 7625369
references: Radiology. 1989 Jan;170(1 Pt 1):211-7
references: 2535765
references: Technol Cancer Res Treat. 2004 Jun;3(3):303-7
references: 15161323
references: Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):381-9
references: 17513061
references: Am J Clin Oncol. 1987 Apr;10(2):156-62
references: 3565314